CC
Catalio Capital Management is a venture capital firm that exclusively focuses on healthcare and life sciences, investing in breakthrough biomedical technologies. Their strategy involves a multi-stage approach, utilizing venture, growth, credit, and public equity strategies to support innovative companies from inception to IPO.
Portfolio
2
Fund Size
$2B
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Proto Axiom | Series B | $20M | Aug 2024 |
| Pheast Therapeutics | Series A | $76M | Apr 2022 |
Top Co-Investors
ARCH Venture Partners1 shared
Alexandria Venture Investments1 shared
Last updated: 26 February 2026